137 related articles for article (PubMed ID: 37246309)
1. Outcomes of extended total mesorectal excision in patients with locally advanced rectal cancer.
Saravanabavan S; Kazi M; Murugan J; Vispute T; Vijayakumaran P; Desouza A; Saklani A
Colorectal Dis; 2023 Jul; 25(7):1423-1432. PubMed ID: 37246309
[TBL] [Abstract][Full Text] [Related]
2. Persistent involvement of anterior mesorectal fascia in carcinoma rectum - extended resection of rectum vs total pelvic exenteration: results from a single-centre retrospective study.
Verma K; Engineer R; Ostwal V; Kumar S; Arya S; Desouza AL; Saklani AP
Colorectal Dis; 2018 Dec; 20(12):1070-1077. PubMed ID: 29985547
[TBL] [Abstract][Full Text] [Related]
3. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
[TBL] [Abstract][Full Text] [Related]
4. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
5. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
6. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
[TBL] [Abstract][Full Text] [Related]
7. The Feasibility and Efficacy of Laparoscopic Extended Total Mesorectal Excision for Locally Advanced Lower Rectal Cancer.
Nonaka T; Fukuda A; Maekawa K; Nagayoshi S; Tokunaga T; Takatsuki M; Kitajima T; Taniguchi K; Fujioka H
In Vivo; 2018; 32(3):643-648. PubMed ID: 29695572
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
[TBL] [Abstract][Full Text] [Related]
9. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
10. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
12. Extended Total Mesorectal Excision (e-TME) for Locally Advanced Rectal Cancer.
Pandit N; Deo KB; Gautam S; Yadav TN; Kafle A; Singh SK; Awale L
J Gastrointest Cancer; 2022 Jun; 53(2):253-258. PubMed ID: 33417198
[TBL] [Abstract][Full Text] [Related]
13. Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.
Khan JS; Piozzi GN; Rouanet P; Saklani A; Ozben V; Neary P; Coyne P; Kim SH; Garcia-Aguilar J
Eur J Surg Oncol; 2024 Jun; 50(6):108308. PubMed ID: 38583214
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
15. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
16. Excision of the seminal vesicles for locally advanced and recurrent rectal and sigmoid cancer.
Keating JP; Manning S; Dennett E; Studd R
ANZ J Surg; 2017 Sep; 87(9):688-691. PubMed ID: 25827193
[TBL] [Abstract][Full Text] [Related]
17. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
18. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
[TBL] [Abstract][Full Text] [Related]
20. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.
Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT
Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
